Norway expressed increasing concern about the safety of the Pfizer Inc. vaccine on elderly people with serious underlying health conditions after raising an estimate of the number who died after receiving inoculations to 29.
The latest figure adds six to the number of known fatalities in Norway, and lowers the age group thought to be affected to 75 from 80
